Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806570 · ClinicalTrials.gov registry record · NA
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
A NA study, sponsored by Ancora Heart.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02806570: Completed NA study, sponsored by Ancora Heart.
NCT02806570 is a NA study that has completed, run by Ancora Heart. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806570, a NA study, has completed, sponsored by Ancora Heart.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy
Primary Outcome
Assess 30-day safety defined as device-related or procedure-related major adverse events (MAEs). MAE is a composite of death; myocardial infarction; emergent conversion to surgery; stroke; major cardiac structure complication; major vascular complication; and heart failure-related hospitalization.
Interventions
- DEVICE Mitral valve repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-08 |
| Est. Completion | 2024-08-22 |
| Phase | NA |
What the finished NCT02806570 record still lists
NCT02806570 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Mitral valve repair is the first listed.
NCT02806570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02806570 about?
NCT02806570 is a clinical study titled "The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study". This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy
What is the current status of trial NCT02806570?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-08. Estimated completion is 2024-08-22.
What interventions are being tested in trial NCT02806570?
The interventions under investigation include: Mitral valve repair (DEVICE).
Who is sponsoring clinical trial NCT02806570?
This trial is sponsored by Ancora Heart, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02806570's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia